Anderson Hoagland & Co’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
LMFP
CIM
ATO
CGH
Anderson Hoagland & Co's GILD Position: Q2 2026 in Review
Anderson Hoagland & Co increased its Gilead Sciences (GILD) stake by 0.17% in Q2 2026, buying an estimated $6.59K and bringing the position to 29,017 shares worth $3.67M. The position accounts for 0.29% of the portfolio, ranked #78.
Anderson Hoagland & Co first reported a position in GILD in Q3 2013 and has held it in 29 quarters since. The position peaked at $4.04M in Q1 2026. 690 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- Anderson Hoagland & Co held 29,017 shares of Gilead Sciences worth $3.67M as of Q2 2026.
- Anderson Hoagland & Co bought 50 Gilead Sciences shares in Q2 2026, an estimated $6.59K.
- Gilead Sciences made up 0.29% of Anderson Hoagland & Co's portfolio in Q2 2026, its #78 holding.
- Anderson Hoagland & Co first reported a position in Gilead Sciences in Q3 2013 and has held it in 29 quarters since.
- Anderson Hoagland & Co's Gilead Sciences position peaked at $4.04M in Q1 2026.
- 690 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on Anderson Hoagland & Co's 13F filing for Q2 2026, filed 6 Jul 2026.